Search Results - "Gutiontov, Stanley I."

CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer by Gutiontov, Stanley I., Turchan, William Tyler, Spurr, Liam F., Rouhani, Sherin J., Chervin, Carolina Soto, Steinhardt, George, Lager, Angela M., Wanjari, Pankhuri, Malik, Renuka, Connell, Philip P., Chmura, Steven J., Juloori, Aditya, Hoffman, Philip C., Ferguson, Mark K., Donington, Jessica S., Patel, Jyoti D., Vokes, Everett E., Weichselbaum, Ralph R., Bestvina, Christine M., Segal, Jeremy P., Pitroda, Sean P.

“…Immune checkpoint blockade (ICB) improves outcomes in non-small cell lung cancer (NSCLC) though most patients progress. There are limited data regarding…”
Get full text

Radiotherapy and Immunotherapy for Cancer: From "Systemic" to "Multisite" by Arina, Ainhoa, Gutiontov, Stanley I, Weichselbaum, Ralph R

“…In the era of cancer immunotherapy, there is significant interest in combining conventional cancer therapies, such as radiotherapy, with drugs that stimulate…”
Get full text

Improved outcomes after radiotherapy for prostate cancer: Anticoagulation, antiplatelet therapy, and platelet count as key factors in disease progression by Gutiontov, Stanley I., Choe, Kevin S., Miller, Jonathan L., Liauw, Stanley L.

“…Background Several studies have suggested that antiplatelet (AP) or anticoagulant (AC) therapy may improve outcome in men with prostate cancer. We evaluated…”
Get full text

The Median Isn't the Message: Revisited by Gutiontov, Stanley I

Get full text

Oligometastasis: Past, Present, Future by Gutiontov, Stanley I., Pitroda, Sean P., Weichselbaum, Ralph R.

“…In this review, we discuss the oligometastatic state, with a focus on its current and future relevance within the field of radiation therapy. We first outline…”
Get full text

(Oligo)metastasis as a Spectrum of Disease by Gutiontov, Stanley I, Pitroda, Sean P, Tran, Phuoc T, Weichselbaum, Ralph R

“…Cancer metastasis is the leading cause of cancer-related mortality, and most patients with metastases from solid tumors have historically been considered…”
Get full text

Cytoreduction and the Optimization Of Immune Checkpoint Inhibition with Radiation Therapy by Gutiontov, Stanley I., Pitroda, Sean P., Chmura, Steven J., Arina, Ainhoa, Weichselbaum, Ralph R.

Get full text

I’m Sorry—A Time to Treat and a Time to Comfort by Gutiontov, Stanley I.

Get full text

STING (or SRC) Like an ICB: Priming the Immune Response in Pancreatic Cancer by Gutiontov, Stanley I, Weichselbaum, Ralph R

“…Pancreatic adenocarcinoma is associated with a poor prognosis and resistance to immune checkpoint blockade. Zhang and colleagues demonstrate that inhibiting…”
Get full text

The Evolution (and Future) of Stereotactic Body Radiotherapy in the Treatment of Oligometastatic Disease by Onderdonk, Benjamin E., Gutiontov, Stanley I., Chmura, Steven J.

“…This review outlines the history of the oligometastatic state from its first proposal to the current formulation. The article discusses the accumulating…”
Get full text

Intensity-modulated radiotherapy for head and neck surgeons by Gutiontov, Stanley I., Shin, Edward J., Lok, Benjamin, Lee, Nancy Y., Cabanillas, Ruben

“…The development of intensity‐modulated radiotherapy (IMRT) has played a major role in improving outcomes and decreasing morbidity in patients with head and…”
Get full text

Informed Consent in Radiation Oncology by Gutiontov, Stanley I., Golden, Daniel W., McCloskey, Susan, Shumway, Dean, Sullivan, Donald R., Wall, Terry J., Gunderson, Leonard L., Jagsi, Reshma

Get full text

Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade by Spurr, Liam F, Martinez, Carlos A, Kang, Wenjun, Chen, Mengjie, Zha, Yuanyuan, Hseu, Robyn, Gutiontov, Stanley I, Turchan, William T, Lynch, Connor M, Pointer, Kelli B, Chang, Paul, Murgu, Septimiu, Husain, Aliya N, Cody, Brittany, Vokes, Everett E, Bestvina, Christine M, Patel, Jyoti D, Diehn, Maximilian, Gajewski, Thomas F, Weichselbaum, Ralph R, Chmura, Steven J, Pitroda, Sean P

“…Over 500 clinical trials are investigating combination radiotherapy and immune checkpoint blockade (ICB) as cancer treatments; however, the majority of trials…”
Get full text

Pilot Study Demonstrating the Value of Interdisciplinary Education on the Integration of Radiation Therapy in Lung Cancer Management by Mattes, Malcolm D., Ye, Jason C., Peters, Gabrielle W., Rizvi, Faryal, Thomas, Tarita O., Chandra, Ravi A., Weiss, Elisabeth, Gutiontov, Stanley I., Motwani, Sabin B.

“…This study aimed to understand baseline knowledge of basic principles of radiation therapy for lung cancer among medical oncology, thoracic surgery, and…”
Get full text

High-dose hypofractionated radiotherapy is effective and safe for tumors in the head-and-neck by Teckie, Sewit, Lok, Benjamin H, Rao, Shyam, Gutiontov, Stanley I, Yamada, Yoshiya, Berry, Sean L, Zelefsky, Michael J, Lee, Nancy Y

“…Highlights • Hypofractionated head and neck radiation therapy is controversial due to toxicity concerns. • 62 sites of measurable head-and-neck tumors were…”
Get full text

Characterizing Lymph Node Burden With Elective Unilateral Neck Irradiation in Human Papillomavirus-Positive Tonsil Squamous Cell Carcinoma: Defining the Upper Limits by Hara, Jared H, Gutiontov, Stanley I, Uddin, Sophia, Rosenberg, Ari J, Pearson, Alexander T, Gooi, Zhen, Blair, Elizabeth A, Agrawal, Nishant, Vokes, Everett E, Ginat, Daniel T, Haraf, Daniel J, Juloori, Aditya

“…ObjectivesElective unilateral neck irradiation in well-lateralized tonsil carcinoma for N2b disease is controversial. Metrics regarding nodal burden beyond the…”
Get full text

STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer by Katipally, Rohan R, Spurr, Liam F, Gutiontov, Stanley I, Turchan, William Tyler, Connell, Philip, Juloori, Aditya, Malik, Renuka, Binkley, Michael S, Jiang, Alice L, Rouhani, Sherin J, Chervin, Carolina Soto, Wanjari, Pankhuri, Segal, Jeremy P, Ng, Victor, Loo, Billy W, Gomez, Daniel R, Bestvina, Christine M, Vokes, Everett E, Ferguson, Mark K, Donington, Jessica S, Diehn, Maximilian, Pitroda, Sean P

“…Molecular factors predicting relapse in early-stage non-small-cell lung cancer (ES-NSCLC) are poorly understood, especially in inoperable patients receiving…”
Get more information

Proton Radiotherapy for Recurrent or Metastatic Head and Neck Cancers with Palliative Quad Shot by Ma, Jennifer, Lok, Benjamin H, Zong, Jingfeng, Gutiontov, Stanley I, Cai, Xin, Bell, Andrew C, Shcherba, Marina, Xiao, Han, Sherman, Eric J, Tsai, Chiaojung Jillian, Riaz, Nadeem, McBride, Sean M, Cahlon, Oren, Lee, Nancy Y

“…Some patients with previously treated, unresectable, recurrent or metastatic head and neck malignancies are not amenable to curative-intent treatment. Here, we…”
Get full text

Proton Radiation Therapy for Local Control in a Case of Osteosarcoma of the Neck by Gutiontov, Stanley I., Zumsteg, Zachary S., Lok, Benjamin H., Berry, Sean, Tsai, Chiaojung J., McBride, Sean M., Riaz, Nadeem, Cahlon, Oren, Lee, Nancy Y.

“…A 33-year-old man with symptomatic, unresectable osteosarcoma of the neck experienced disease progression despite treatment with multiple systemic agents…”
Get full text

Abstract 799: CDKN2A mutation predicts immunotherapy resistance in stage III/IV NSCLC by Gutiontov, Stanley I., Pitroda, Sean

“…Purpose: Immune checkpoint blockade (ICB) has improved outcomes for patients with non-small cell lung cancer (NSCLC). However, most patients experience disease…”
Get full text